GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 103 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,190,771 | -31.0% | 5,924,867 | -21.8% | 0.03% | -31.8% |
| Q2 2023 | $14,768,676 | -30.8% | 7,573,680 | -1.4% | 0.04% | -33.3% |
| Q1 2023 | $21,350,030 | -19.4% | 7,679,867 | 0.0% | 0.07% | -26.7% |
| Q4 2022 | $26,495,541 | +1514.6% | 7,679,867 | +4313.7% | 0.09% | +1025.0% |
| Q1 2021 | $1,641,000 | +1055.6% | 174,000 | +1640.0% | 0.01% | +700.0% |
| Q3 2018 | $142,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |